Understanding and Assessing the Impact of End-Stage Renal Disease on Quality of Life
- 200 Downloads
Advances in healthcare, combined with an increasing number of adults with end-stage renal disease (ESRD), mean that there is a growing number of people now surviving on renal replacement therapy. The issue of health-related quality of life (HR-QOL) is becoming increasingly important in this area. For this reason, the content validity of various instruments used to measure HR-QOL in an ESRD population were explored.
Systematic searches of MEDLINE (1950–2009) were conducted using terms related to ESRD combined with terms associated with measuring HR-QOL. A total of 378 abstracts were identified, detailing the repeated use of six generic measures and four disease-specific measures. The generic HR-QOL measures discussed include the Medical Outcomes 36-Item Short Form Survey (SF-36), the EuroQOL 5 Dimension (EQ-5D), and the WHO QOL assessment (WHOQOL-BREF). The most frequently used disease-specific measure discussed is the Kidney Disease QOL instrument (KDQOL) and its derivative versions (KDQOL-SF, KDQOL-36).
The appropriateness of using the SF-36 in this population is challenged and recommendations include using the WHOQOL-BREF in cases when a generic instrument is required and the KDQOL-SF when a more disease-specific measurement is called for.
KeywordsRenal Replacement Therapy Continuous Ambulatory Peritoneal Dialysis Sickness Impact Profile Automate Peritoneal Dialysis Continuous Ambulatory Peritoneal Dialysis Patient
No sources of funding were used to conduct this study or prepare this review. The authors have no conflicts of interest that are directly relevant to the content of this review.
- 1.Ken Farrington AH, Casula A, Ansell D, et al. UK Renal Registry 11th Annual Report. Bristol: UK Renal Registry, 2008 [online]. Available from URL: http://www.renalreg.com/Reports/2008.html [Accessed 2011 Jan 6]Google Scholar
- 2.Cross Party Group on Kidney Disease. Renal disease in Scotland: a strategy for future management. Edinburgh: The Scottish Parliament, 2004 [online]. Available from URL: http://www.renal.org/Libraries/UK_Nephrology/Renal_Disease_in_Scotland_A_Strategy_For_Future_Management_April_2004.sflb.ashx [Accessed 2010 Dec 20]Google Scholar
- 3.Levy J, Pusey C, Singh A. Fast facts: renal disorders. Oxford: Health Press, 2006Google Scholar
- 5.Bowling A. Measuring health: a review of quality of life measurement scales. 3rd ed. Maidenhead: Open University Press, 2005Google Scholar
- 6.Phillips D. Quality of life: concept, policy and practice. London: Routledge, 2006Google Scholar
- 10.Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948Google Scholar
- 36.Theodora K, Christina D, Tania F, et al. Looking in to the factors affecting renal patients’ quality of life. EDTNA J 1996; 23(3): 19–21Google Scholar
- 41.Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, et al. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol 2000; 11(2): 335–42PubMedGoogle Scholar
- 50.Provenzano R, Garcia-Mayol L, Suchinda P, et al. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. Clinical Nephrol 2004 Jun; 61(6): 392–405Google Scholar
- 53.Franke GH, Yucetin L, Yaman H, et al., editors. Disease-specific quality of life in Turkish patients after successful kidney transplantation. 8th Meeting of the Turkish-Transplantation-Society; 2005 Jun 22–24; Ankara. New York: Elsevier Science Inc., 2006Google Scholar
- 55.Cetingok M, Winsett RP, Hathaway DK. A comparative study of quality of life among the age groups of kidney transplant recipients. Prog Transplant 2004; 14(1): 33–8Google Scholar